Salivary Lactate Dehydrogenase as a Predictive Marker for Radiation-induced Dermatitis in Head and Neck Cancers: A Preliminary Study

Shivashankara, Arnadi R.; Pais, Saira; Simon, Paul; Kalekhan, Faizan M.; Lobo, Ashwin DA.; Suresh, Sucharitha; Tonse, Raees; George, Thomas; Baliga, Manjeshwar Srinath

doi:10.30476/mejc.2022.88673.1485

Salivary Lactate Dehydrogenase as a Predictive Marker for Radiation-induced Dermatitis in Head and Neck Cancers: A Preliminary Study

Document Type : Original Article(s)

Authors

Arnadi R. Shivashankara ¹

Saira Pais ²

Paul Simon ³

Faizan M. Kalekhan ³

Ashwin DA. Lobo ¹

Sucharitha Suresh ⁴

Raees Tonse ²

Thomas George ³

Manjeshwar Srinath Baliga ³

¹ Department of Biochemistry, Father Muller Medical College, Mangalore, Karnataka, India

² Department of Radiation Oncology, Father Muller Medical College, Mangalore, Karnataka, India

³ Father Muller Research Centre, Mangalore, Karnataka, India

⁴ Department of Community Medicine, Father Muller Medical College, Mangalore, Karnataka, India

https://doi.org/10.30476/mejc.2022.88673.1485

Abstract

Background: Radiation dermatitis is known to be a major side-effect occurring following cancer treatment. We conducted the present study to understand whether salivary lactate dehydrogenase (LDH) could be conducive to predict the development of radiation-dermatitis in the head and neck cancer (HNC) patients undergoing curative radiotherapy (60-70 Gy).
Method: This was a prospective study performed on HNC patients requiring curative radiotherapy. Saliva was collected at two points from the willing volunteers. The first time point was prior to the first fraction of 2 Gy radiation and the second one was 24 hours after the first fraction and before exposure to the second fraction. The saliva collected at the both time points were analyzed for the levels of salivary LDH using standard procedure. The patients were provided with the standard care throughout the treatment period and the incidence and severity of radiation dermatitis was noted down using a proforma sheet throughout the 7-week treatment period.
Results: The results suggested that with exposure to 2 Gy fraction, there was an increase in the level of salivary LDH (387.11 ± 18.98 IU/L vs. 368. 13 ± 19.56IU/L); this increase was significant (t = 20.06 and P < 0.001). The LDH data was stratified based on the severity of dermatitis [mild (grades 1 and 2) vs. severe (grades 3 and 4)] in accordance to the Radiation Therapy Oncology Group/European Organization for Research and Treatment Cancer (RTOG) grading. The LDH values were subjected to Karl Pearson’s correlation analysis with the grade of dermatitis and the results indicated a P value of 0.019 and R value of 0.24.
Conclusion: For the first time, our study revealed that salivary LDH could be a useful marker to understand the development of radiation-induced dermatitis in HNC patients undergoing curative radiotherapy. The most advantageous aspect herewith is that the collection of saliva does not require skilled people or special equipment; it cou ld be done at repeated intervals and without causing any invasive process.

Keywords

Head and neck neoplasms

Saliva

Lactate dehydrogenase

Radiotherapy

Radiodermatitis

How to cite this article:

Shivashankara AR, Pais S, Simon P, Kalekhan FM, Lobo AD, Suresh S, et al. Salivary lactate dehydrogenase as a predictive marker for radiation-induced dermatitis in head and neck cancers: a preliminary study. Middle East J Cancer. 2022;13(4):607-15. doi: 10. 30476/mejc.2022.88673.1485.

1. Ratko TA, Douglas GW, de Souza JA, et al. Radiotherapy Treatments for Head and Neck Cancer Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. (Comparative Effectiveness Review, No. 144.) Introduction. Available from: https://www.ncbi.nlm.nih. gov/books/NBK269010/
2. Baskar R, Dai J, Wenlong N, Yeo R, Yeoh KW. Biological response of cancer cells to radiation treatment. Front Mol Biosc. 2014;1:24.
3. Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: A review of our current understanding. Am J Clin Dermatol 2016;17(3):277-292.
4. Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia. Am J Health Syst Pharm. 2013;70(12):1025-1032.
5. Mehta S, Shelling A, Muthukaruppan A, Lasham A, Blenkiron C, Laking G, et al. Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol. 2010; 2(2):125-48.
6. Adeva-Andany M, López-Ojén M, Funcasta-Calderón R, Ameneiros-Rodríguez E, Donapetry-García C, Vila-Altesor M, et al. Comprehensive review on lactate metabolism in human health. Mitochondrion. 2014;17:76-100. doi: 10.1016/j.mito.2014.05.007.
7. Huijgen HJ, Sanders GT, Koster RW, Vreeken J, Bossuyt PM. The clinical value of lactate dehydrogenase in serum: a quantitative review. Eur J Clin Chem Clin Biochem. 1997;35(8):569-79.
8. Nakazawa M, Leith JT, Glicksman AS. X-ray responses of human colon tumor cells grown in artificial capillary culture. J Natl Cancer Inst. 1984;72(6):1261-9.
9. Thomas P, Tracy B, Ping T, Baweja A, Wickstrom M, Sidhu N, et al. Relative biological effectiveness (RBE) of alpha radiation in cultured porcine aortic endothelial cells. Int J Radiat Biol. 2007;83(3):171-9. doi: 10.1080/09553000601146915.
10. Hwang JM, Chan DC, Chang TM, Tsao TY, Tsou SS, Lu RH, et al. Effects of oral arginine and glutamine on radiation-induced injury in the rat. J Surg Res. 2003;109(2):149-54. doi: 10.1016/s0022-4804(02) 00096-3.
11. Saada HN, Said UZ, Meky NH, Abd El Azime AS. Grape seed extract Vitis vinifera protects against radiation-induced oxidative damage and metabolic disorders in rats. Phytother Res. 2009;23(3):434-8. doi: 10.1002/ptr.2684.
12. Abou-Zeid SM, El-Bialy BE, El-Borai NB, AbuBakr HO, Elhadary AMA. Radioprotective effect of date syrup on radiation- induced damage in Rats. Sci Rep. 2018;8(1):7423. doi: 10. 1038/s41598-018-25586-3.
13. Horváth M, Rodé IL, Kralovánszky J, Volant M. Investigation of a valuable biochemical indicator in radiotherapy. III. Serum lactate dehydrogenase enzyme level on irradiation of cancer patients. Strahlentherapie. 1980;156(4):244-7.
14. Miyazawa K, Shikama N, Okazaki S, Koyama T, Takahashi T, Kato S. Predicting prognosis of short survival time after palliative whole-brain radiotherapy. J Radiat Res. 2018;59(1):43-9. doi: 10.1093/jrr/rrx058.
15. Shivashankara AR, Tonse R, Suresh S, George T, Vidyasagar MS, Rao S, et al. Salivary lactate dehydrogenase (LDH) as a marker for radiation-induced mucositis in head and neck cancers: A preliminary study. Middle East J Cancer. 2019;10(2):103-10. doi: 10.30476/mejc.2019.81573. 1027.
16. Lavertu P, Adelstein DJ, Saxton JP, Secic M, Wanamaker JR, Eliachar I, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck. 1997;19(7):559-66. doi: 10.1002/(sici)1097-0347(199710)19: 7<559::aid-hed1>3.0.co;2-6.
17. Marcu LG. Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments. Bio Med Res Int. 2013; 2013: 817279. doi:10. 1155/2013/817279.
18. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72-7. doi: 10.1111/j.1749-6632.1993.tb18343.x.
19. Demetriou JA, Drewes PA, Gin JB, Enzymes. In: Henry RJ, Cannon DC, Winkelman JW, editors. Clinical chemistry: Principles and techniques. New York: Haper and Row; 1974.
20. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341-6. doi: 10.1016/0360-3016(95)00060-C.
21. Noble-Adams R. Radiation-induced reactions. 1: An examination of the phenomenon. Br J Nurs. 1999;8(17):1134-40. doi: 10.12968/bjon.1999.8. 17.6503.
22. Noble-Adams R. Radiation-induced skin reactions. 2: Development of a measurement tool. Br J Nurs. 1999;8(18):1208-11. doi: 10.12968/bjon.1999.8.18. 6490.
23.Khanal B, Baliga M, Uppal N. Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study. Int J Oral Maxillofac Surg. 2010;39(12):1181-5. doi: 10.1016/j.ijom.2010.05.014.
24. Ki Y, Kim W, Nam J, Kim D, Park D, Kim D. C-reactive protein levels and radiation-induced dermatitis in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;75(2): 393-8.
25. Mohammed FF, Poon I, Zhang L, Elliott L, Hodson ID, Sagar SM, et al. Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. Head Neck. 2012;34(7):985-93. doi: 10.1002/hed.21848.
26. Rao S, Hegde SK, Baliga-Rao MP, Palatty PL, George T, Baliga MS. An Aloe Vera-based cosmeceutical cream delays and mitigates ionizing radiation-induced dermatitis in head and neck cancer patients undergoing curative radiotherapy: A clinical study. Medicines (Basel). 2017;4(3):44. doi: 10. 3390/medicines 4030044.
27. Mizawa M, Yamaguchi M, Ueda C, Makino T, Shimizu T. Stress evaluation in adult patients with atopic dermatitis using salivary cortisol. BioMed Res Int. 2013; 2013:138027. doi: 10. 1155/2013/138027.
28. Cho SK, Kim WD. Early diagnosis of radiodermatitis using lactate dehydrogenase isozymes in hairless mice (SKH1-hr). Lab Anim Res. 2012;28(4):239-44.
29. Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol. 2007;133(9):613-7.
30. Jurisic V, Radenkovic S, Konjevic G. The actual role of LDH as tumor marker, biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:115-24.
31. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703-7. doi: 10.1016/j.cell.2008.08.021.
32. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Trarbach T, Folprecht G, et al. Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy. Clin Cancer Res. 2011;17(14):4892-900. doi: 10.1158/1078-0432.CCR-10-2918.
33. Turen S, Ozyar E, Altundag K, Gullu I, Atahan IL. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Cancer Invest. 2007;25(5):315-21. doi: 10.1080/07357900701209103.
34. Hermes A, Gatzemeier U, Waschki B, Reck M. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis. Respir Med. 2010;104(12):1937-42. doi: 10.1016/j.rmed.2010. 07.013.
35. Brown JE, Cook RJ, Lipton A, Coleman RE. Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients. Clin Cancer Res. 2012;18(22):6348-55. doi: 10.1158/1078-0432.CCR-12-1397.
36. Halabi S, Small EJ, Kantoff PW, Kattan MW, Kaplan EB, Dawson NA, et al. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol. 2003;21(7):1232-7. doi: 10.1200/JCO.2003.06.100. Erratum in: J Clin Oncol. 2004;22(16):3434.
37. Gerlinger M, Wilson P, Powles T, Shamash J. Elevated LDH predicts poor outcome of recurrent germ cell tumours treated with dose dense chemotherapy. Eur J Cancer. 2010;46(16):2913-8. doi: 10.1016/j. ejca.2010.07.004.
38. Egberts F, Kotthoff EM, Gerdes S, Egberts JH, Weichenthal M, Hauschild A. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma. Eur J Cancer. 2012;48(5):695-702. doi: 10.1016/j.ejca.2011.08.007.
39. Turna A, Solak O, Cetinkaya E, Kiliçgün A, Metin M, Sayar A, et al. Lactate dehydrodgenase levels predict pulmonary morbidity after lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;26(3):483-7. doi: 10.1016/j.ejcts.2004.05.041.
40. Atzpodien J, Royston P, Wandert T, Reitz M; DGCIN - German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer. 2003;88(3):348-53. doi: 10.1038/sj.bjc. 6600768.
41. Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res. 2016;6(1):66-75. doi: 10.1016/j.jobcr.2015.08.006.
42. Lokesh K, Kannabiran J, Rao MD. Salivary lactate dehydrogenase (LDH)- A novel technique in oral cancer detection and diagnosis. J Clin Diagn Res. 2016;10(2):ZC34-7. doi: 10.7860/JCDR/2016/ 16243.7223.
43. Iglesias-Velázquez Ó, López-Pintor RM, González-Serrano J, Casañas E, Torres J, Hernández G. Salivary LDH in oral cancer and potentially malignant disorders: A systematic review and meta-analysis. Oral Dis. 2022;28(1):44-56. doi: 10.1111/odi.13630.